Advanced Accelerator Applications S.A. (NASDAQ:AAAP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, July 11th. The firm currently has a $44.00 target price on the stock. Zacks Investment Research‘s price objective points to a potential downside of 9.48% from the stock’s previous close.

According to Zacks, “Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The company, develops, produces and commercializes molecular nuclear medicine diagnostic and therapeutic products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The company’s commercial products include Gluscan /Gluscan 500/Barnascan(R), IASOflu(R), IASOdopa(R), IASOcholine(R), MIBITEC/Adamibi and Leukokit(R). It operates primarily in France, Italy, the United Kingdom, Spain, Portugal, Israel, Switzerland, Germany and Canada. Advanced Accelerator Applications S.A. is headquartered in Saint Genis Pouilly, France. “

AAAP has been the subject of a number of other reports. J P Morgan Chase & Co assumed coverage on Advanced Accelerator Applications in a report on Thursday, June 15th. They issued an “overweight” rating and a $50.00 price target for the company. TheStreet raised Advanced Accelerator Applications from a “d” rating to a “c-” rating in a report on Thursday, March 23rd. Canaccord Genuity set a $47.00 price target on Advanced Accelerator Applications and gave the stock a “buy” rating in a report on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “buy” rating and issued a $50.00 price target on shares of Advanced Accelerator Applications in a report on Friday, March 24th. Finally, BidaskClub raised Advanced Accelerator Applications from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Advanced Accelerator Applications currently has an average rating of “Buy” and a consensus target price of $52.00.

Advanced Accelerator Applications (NASDAQ AAAP) traded down 2.02% during mid-day trading on Tuesday, hitting $48.61. The stock had a trading volume of 48,463 shares. The firm’s 50-day moving average is $41.26 and its 200 day moving average is $37.70. The company’s market cap is $2.14 billion. Advanced Accelerator Applications has a 12 month low of $23.50 and a 12 month high of $51.02.

COPYRIGHT VIOLATION NOTICE: “Advanced Accelerator Applications S.A. (NASDAQ:AAAP) Stock Rating Upgraded by Zacks Investment Research” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/08/advanced-accelerator-applications-s-a-nasdaqaaap-upgraded-at-zacks-investment-research-updated-updated-updated.html.

A number of large investors have recently bought and sold shares of the stock. Alps Advisors Inc. raised its stake in Advanced Accelerator Applications by 4.9% in the second quarter. Alps Advisors Inc. now owns 39,694 shares of the company’s stock valued at $1,550,000 after buying an additional 1,861 shares in the last quarter. JPMorgan Chase & Co. acquired a new stake in Advanced Accelerator Applications during the first quarter valued at about $160,000. Geode Capital Management LLC raised its stake in Advanced Accelerator Applications by 32.6% in the first quarter. Geode Capital Management LLC now owns 22,095 shares of the company’s stock valued at $880,000 after buying an additional 5,438 shares in the last quarter. Birchview Capital LP acquired a new stake in Advanced Accelerator Applications during the first quarter valued at about $279,000. Finally, KCG Holdings Inc. acquired a new stake in Advanced Accelerator Applications during the first quarter valued at about $338,000. 40.90% of the stock is owned by institutional investors.

Advanced Accelerator Applications Company Profile

Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.

Get a free copy of the Zacks research report on Advanced Accelerator Applications (AAAP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Advanced Accelerator Applications (NASDAQ:AAAP)

Receive News & Stock Ratings for Advanced Accelerator Applications S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications S.A. and related stocks with our FREE daily email newsletter.